Beginning to Understand the End of the Chromosome

Modern Biopharmaceuticals: Design, Development and Optimization

Volumn 1, Issue , 2008, Pages 36-48

  Cech, Thomas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Biopharmaceuticals; Blackburn; Fission yeast; Perturbing; Telomerase

Indexed keywords

EID: 84889992878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527620982.ch1     Document Type: Chapter

References (73)

1. Hall, S. S. (2003) Merchants of Immortality (New York: Houghton Miffin Company).
2. Blackburn, E.H. (2001). Switching and signaling at the telomere. Cell 106, 661-673.
3. Collins, K., and Mitchell, J. R. (2002). Telomerase in the human organism. Oncogene 21, 564-579.
4. Szostak, J.W., and Blackburn, E.H. (1982). Cloning yeast telomeres on linear DNA plasmid vectors. Cell 29, 245-255.
5. Pluta, A. F., Cani, G. M., Spear, B. B., and Zakian, V. A. (1984). Elaboration of telomeres in yeast: recognition and modification of termini from Oxytricha macronuclear DNA. Proc. Natl. Acad. Sci. USA 81, 1475-1479.
6. Shampay, J., Szostak, J.W., and Blackburn, E.H. (1984). DNA sequences of telomeres maintained in yeast. Nature 310, 154-157.
7. Greider, C.W., and Blackburn, E.H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
8. Greider, C.W., and Blackburn, E.H. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 331-337.
9. Cech, T. R. (1994). Chromosome end games. Science 266, 387-388.
10. Yu, G. L., Bradley, J. D., Attardi, L. D., and Blackburn, E.H. (1990). In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344, 126-132.
11. Feng, J., Funk, W. D., Wang, S., Weinrich, S. L., Avilion, A. A., Chiu, C., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
12. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C.W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
13. Lingner, J., and Cech, T. R. (1996). Purification of telomerase from Euplotes aediculatus: Re-quirement of a primer 3' overhang. Proc. Natl. Acad. Sci. USA 93, 10712-10717.
14. Lendvay, T. S., Morris, D.K., Sah, J., Balasubramanian, B., and Lundblad, V. (1996). Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144, 1399-1412.
15. Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T. R. (1997). Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561-567.
16. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L.W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
17. Nakamura, T. M., Morin, G.B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
18. Bryan, T. M., Goodrich, K. J., and Cech, T. R. (2000). Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol. Cell 6, 493-499.
19. Friedman, K. L., Heit, J. J., Long, D.L., and Cech, T. R. (2003). N-terminal domain of yeast telomerase reverse transcriptase: recruitment of Est3p to the telomerase complex. Mol. Biol. Cell 14, 1-13.
20. Chen, J.-L., Blasco, M.A., and Greider, C.W. (2000). Secondary structure of vertebrate telomerase RNA. Cell 100, 503-514.
21. Lundblad, V., and Szostak, J.W. (1989). A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57, 633-643.
22. Pennock, E., Buckley, K., and Lundblad, V. (2001). Cdc13 delivers separate complexes to the telomere for end protection and replication. Cell 104, 387-396.
23. Taggart, A. K. P., Teng, S.-C., and Zakian, V. A. (2002). Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science 297, 1023-1026.
24. Reichenbach, P., Hoss, M., Azzalin, C. M., Nabholz, M., Bucher, P., and Lingner, J. (2003). A human homolog of yeast est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr. Biol. 13, 568-574.
25. Snow, B. E., Erdmann, N., Cruickshank, J., Goldman, H., Gill, R. M., Robinson, M. O., and Harrington, L. (2003). Functional conservation of the telomerase protein est1p in humans. Curr. Biol. 13, 698-704.
26. Stellwagen, A. E., Haimberger, Z.W., Veath, J. R., and Gottschling, D.E. (2003). Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends. Genes Dev. 17, 1-11.
27. Seto, A. G., Zaug, A. J., Sobel, S. G., Wolin, S. L., and Cech, T. R. (1999). Saccharomyces cerevisiae telomerase in an Sm small nuclear ribonucleoprotein particle. Nature 401, 177-180.
28. Ferrezuelo, F., Steiner, B., Aldea, M., and Futcher, B. (2002). Biogenesis of yeast telomerase depends on the importin Mtr10. Mol. Cell. Biol. 22, 6046-6055.
29. Teixeira, M.T., Förstermann, K., Gasser, S. M., and Lingner, J. (2002). Intracellular trafficking of yeast telomerase components. EMBO Rep. 3, 652-659.
30. Mitchell, J. R., and Collins, K. (2000) Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase in vivo and in vitro. Mol. Cell 6, 361-371.
31. Pogacic, V., Dragon, F., and Filipowicz, W. (2000). Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell. Biol. 20, 9028-9040.
32. Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., and Dokal, J. (2001). The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432-435.
33. Aigner, S., Postberg, J., Lipps, H.J., and Cech, T. R. (2003). The Euplotes La motif protein p43 has properties of a telomerase-specific subunit. Biochemistry 42, 5736-5747.
34. Mitchell, J. R., Wood, E., and Collins, K. (1999). A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555.
35. Chen, J.-L., Opperman, K. K., and Greider, C.W. (2002). A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res. 30, 592-597.
36. Livengood, A. J., Zaug, A. J., and Cech, T. R. (2002). Essential regions of Saccharomyces cerevisiae telomerase RNA: separate elements for Est1p and Est2p interaction. Mol. Cell. Biol. 22, 2366-2374.
37. Seto, A. G., Livengood, A. J., Tzfati, Y., Blackburn, E. H., and Cech, T. R. (2002). A bulged stem tethers Est1p to telomerase RNA in budding yeast. Genes Dev. 16, 2800-2812.
38. Tzfati, Y., Fulton, T. B., Roy, J., and Blackburn, E.H. (2000). Template boundary in a yeast telomerase specified by RNA structure. Science 288, 863-867.
39. Chen, J.-L., and Greider, C.W. (2003). Template boundary definition in mammalian telomerase. Genes Dev. 27, 2747-2752.
40. Miller, M. C., and Collins, K. (2002). Telomerase recognizes its template by using an adjacent RNA motif. Proc. Natl. Acad. Sci. USA 99, 6585-6590.
41. Ly, H., Xu, L., Rivera, M.A., Parslow, T. G., and Blackburn, E.H. (2003). A role for a novel "trans-pseudoknot" RNA-RNA-interaction in the functional dimerization of human telomerase. Genes Dev. 17, 1078-1083.
42. Bryan, T. M., Goodrich, K. J., and Cech, T. R. (2003). Tetrahymena telomerase is active as a monomer. Mol. Biol. Cell 14, 4794-4804.
43. Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., and Shay, J.W. (1996). Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173-179.
44. Szutorisz, H., Lingner, J., Cuthbert, A. P., Trott, D.A., Newbold, R. F., and Nabholz, M. (2003). A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin. Cancer Res. 63, 689-695.
45. Lin, S.-Y., and Elledge, S. J. (2003). Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889.
46. Masutomi, K., Yu, E.Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M.W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003). Telomerase maintains telomere structure in normal human cells. Cell 114, 241-253.
47. Ulaner, G. A., Hu, J., Vu, T. H., Giudice, L. C., and Hoffman, A.R. (1998). Telomerase activity in human development is regulated by hTERT transcription and by alternate splicing. Cancer Res. 58, 4168-4172.
48. Marcand, S., Gilson, E., and Shore, D. (1997). A protein-counting mechanism for telomere length regulation in yeast. Science 275, 986-990.
49. Ray, A., and Runge, K.W. (1999). The yeast telomere length counting machinery is sensitive to sequences at the telomere-nontelomere junction. Mol. Cell. Biol. 19, 31-45.
50. Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., and de Lange, T. (2000). Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20, 1659-1668.
51. Kim, S. H., Kaminker, P., and Campisi, J. (1999). TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23, 405-412.
52. Li, B., Oestreich, S., and de Lange, T. (2000). Identification of human Rap1: implications for telomere evolution. Cell 101, 471-483.
53. Kanoh, J., and Ishikawa, F. (2001). spRap1 and spRif1, recruited to telomeres by Taz1, are essential for telomere function in fission yeast. Curr. Biol. 11, 1624-1630.
54. Sadaie, M., Naito, T., and Ishikawa, F. (2003). Stable inheritance of telomere chromatin structure and function in the absence of telomeric repeats. Genes Dev. 17, 2271-2282.
55. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. (1999). Mammalian telomeres end in a large duplex loop. Cell 97, 503-514.
56. Baumann, P., and Cech, T. R. (2001). Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175.
57. Lei, M., Podell, E., Baumann, P., and Cech, T. R. (2003). DNA self-recognition in the structure of Pot1 bound to telomeric singlestranded DNA. Nature 426, 198-203.
58. Loayza, D., and de Lange, T. (2003). POT1 as a terminal transducer of TRF1 telomere length control. Nature 424, 1013-1018.
59. Colgin, L. M., Baran, K., Baumann, P., Cech, T. R., and Reddel, R. R. (2003). Human POT1 is a positive regulator of telomere length. Curr. Biol. 13, 942-946.
60. Jacob, N.K., Kirk, K. E., and Price, C.M. (2003). Generation of telomeric G strand overhangs involves both G and C strand cleavage. Mol. Cell 11, 1021-1032.
61. Kim, M.Y., Vankayalapati, H., Shin-Ya, K., Wierzba, K., and Hurley, L.H. (2002). Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J. Am. Chem. Soc. 124, 2098-2099.
62. Harley, C. B., Futcher, A. B., and Greider, C.W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
63. Bodnar, A. G., Quellette M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J.W., Lichtsteiner, S., and Wright, W. E. (1988). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
64. Hooijberg, E., Ruizendaal, J. J., Sniders, P. J., Kueter, E.W., Walboomers, J. M., and Spits, H. (2000). Immortalization of human CD8+T cell clones by ectopic expression of telomerase reverse transcriptase. J. Immunol. 165, 4239-4245.
65. Rufer, N., Migliaccio, M., Antonchuk, J., Humphries, R. K., Roosnek, E., and Lansdorp, P.M. (2001). Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 98, 597-603.
66. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
67. Karlseder, J., Smogorzewska, A., and de Lange, T. (2002). Senescence induced by altered telomere state, not telomere loss. Science 295, 2446-2449.
68. Dunham, M.A., Neumann, A. A., Fasching, C. L., and Reddel, R. R. (2000). Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450.
69. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M.W., and Weinberg, R. A. (1999 a). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468.
70. Hahn, W. C., Dessain, S. K., Brooks, M.W., King, J. E., Elenbaas, B., Sabatini, D.M., DeCaprio, J. A., and Weinberg, R. A. (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22, 2111-2123.
71. Hahn, W. C., Stewart, S. A., Brooks, M.W., York, S. G., Eaton, E. N., Kurachi, A., Beijersbergen, R. L., Knoll, J.H.M., Meyerson, M., and Weinberg, R.A. (1999 b). Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164-1170.
72. Zhang, X., Mar, V., Zhou, W., Harrington, L., and Robinson, M.O. (1999). Telomerer shortening and apoptosis in telomere-inhibited human tumor cells. Genes Dev. 13, 2388-2399.
73. Damm, K., Hemmann, U., Garin-Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958-6968.